Ultra sensitive and quantitative method for non-invasive cancer detection.
–HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch
–Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer
–Naveris, Inc. to provide NavDx® blood test to Cancer Centers of Excellence
–Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
–HPV blood test shows promise for tracking head and neck cancer after treatment